focus -WSS

focus

author：fashion 2025-10-03 00:36:06 - browse：29875

Stoke Therapeutics is still seeking an effective dose for an experimental drug to treat a severe form of childhood epilepsy, following the release of updated data Tuesday that showed disappointing reductions in convulsive seizure activity.

In the latest look at an ongoing mid-stage study, three monthly injections of the Stoke drug, called STK-001, given at a 45-mg dose, resulted in a median 18% reduction in convulsive seizure activity, compared to baseline.

The new analysis was conducted on 16 children diagnosed with a rare form of epilepsy called Dravet syndrome. Last November, in six patients, the drug showed a median 55% reduction in seizure activity.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Medicare to pay more for cardiac rehab in hospital outpatient clinics

hotspot

WSS

Transgender sports debate: Physicians say bans are health issue

Transgender sports debate: Physicians say bans are health issue

What happened to the House vote on health price transparency?

Akili changes sales model for its ADHD video game treatment

FDA panel to weigh safety of artificial wombs for preterm births

Free Covid tests will again be offered to all U.S. households

Wikipedia

focus

leisure time

Affirmative action in medical school literally saved lives

Why the drug industry's warnings on the IRA's impact fall short

What does generative AI mean for health care? We asked experts

Why we need to separate burnout from moral injury in health care

In Memoriam: Notable people who died in 2023

Weight bias in eating disorder treatment complicated by new weight loss drugs

23andMe had bad news about my health. I wish a person had delivered it

Why the drug industry's warnings on the IRA's impact fall short

Virginia high school admissions case could be legal follow

Why the quest to eradicate polio has stumbled

focus

'A game

White House Covid adviser calls on docs to combat misinformation

People with substance use disorder deserve online privacy

PBMs drew scrutiny in House hearing — and so did pharma

What happened to the House vote on health price transparency?

Free Covid tests will again be offered to all U.S. households

entertainment

hotspot

focus

focus